Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane‐induced lupus nephritis in mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|181|3|407-416

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.3, 2015-09, pp. : 407-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 268, Iss. 1, 2015-11 ,pp. : 123-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suppression of Autoimmunity and Renal Disease in Pristane‐Induced Lupus by Myeloperoxidase

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1868-1880

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologic Therapy in Lupus Nephritis

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 255-260

Karger

Access to resources Recommend Favorite

Interaction of Human IgE with Fc Epsilon RI Alpha Exposes Hidden Epitopes on IgE

By  

International Archives of Allergy and Immunology, Vol. 120, Iss. 4, 1999-12 ,pp. : 295-302

Karger

Access to resources Recommend Favorite

Treatment of lupus nephritis: practical issues in Asian countries

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 2, 2015-02 ,pp. : 138-145

John Wiley & Sons Inc

Access to resources Recommend Favorite